시장보고서

상품코드

1553451

면역조절제 시장 규모, 점유율, 동향 분석 보고서 : 솔루션별, 제품별, 용도별, 지역별, 부문별 예측(2024-2030년)

Immunomodulators Market Size, Share & Trends Analysis Report By Solution, By Product (Immunosuppressants, Immunostimulants), By Application (Oncology, Respiratory, HIV), By Region, And Segment Forecasts, 2024 - 2030

발행일: 2024년 08월 | 리서치사:

Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

면역조절제 시장 성장 및 동향:

Grand View Research, Inc.의 최신 보고서에 따르면 세계 면역조절제 시장 규모는 2030년까지 3억 2,980만 달러에 달할 것으로 예상되며, 2024년부터 2030년까지 연평균 6.2%로 확대될 것으로 예상됩니다.

이 시장은 유명 기업들의 고액 R&D 투자가 주요 원동력이 될 것으로 예상되며, 이는 치료 효과가 뛰어난 신약의 대량 생산으로 이어질 것으로 전망됩니다. 이에 따라 면역조절제 시장에는 전례 없는 속도로 약물이 유입되어 많은 자가면역질환 및 염증성 질환에 대한 매우 효과적인 치료 옵션을 제공할 것으로 예상됩니다.

또한, 약물 내성 증가로 인해 표적 치료 메커니즘을 가진 차세대 면역조절제 개발에 대한 임상적 시급성이 높아질 것으로 예측됩니다. 앞서 언급한 요인들이 복합적으로 작용하여 예측 기간 동안 큰 성장 기회를 제공할 것으로 예상됩니다.

또한, 주요 기업들의 빠른 성장으로 환자뿐만 아니라 의사들 사이에서도 면역조절제의 유용성에 대한 인식이 높아질 것으로 예상됩니다. 이는 예측 기간 동안 면역조절제 산업의 성장 잠재력을 더욱 확대할 것으로 예상됩니다.

또한, 다발성 경화증, 크론병, 류마티스 관절염, 비호지킨 림프종 등 다양한 적응증에 대한 단클론항체의 채택이 증가하면서 예측 기간 동안 면역조절제 산업을 견인할 것으로 예상됩니다. 자가면역질환에서 매우 중요한 단클론항체의 일관된 제품 승인 건수는 성장 범위를 확대하는 요인이 될 것으로 예측됩니다.

면역조절제 시장 보고서 하이라이트

이식 수술의 증가와 장기 거부반응 예방의 필요성으로 인해 2023년에는 면역억제제가 제품 분야에서 가장 큰 점유율을 차지했습니다.
신장 이식, 간 이식, 심장 이식, 폐 이식에서의 사용 확대와 수익 증가로 인해 2023년 항체가 면역억제제 중 압도적인 점유율을 차지했습니다.
면역증강제는 HIV, 암, 다발성 경화증에 적용하기 위한 면역증강제 제네릭 의약품의 유입이 감소함에 따라 높은 성장이 예상됩니다.
2023년 북미가 세계 면역조절제 시장을 독점했는데, 이는 대규모 상업화에 참여하는 다수의 검증된 제약사가 존재하기 때문입니다.
유력한 진입 기업들은 신약을 창출하고 경쟁 우위를 확보하기 위해 연구 및 임상 공동 전략을 시행하고 있습니다.
예를 들어, 2024년 3월 Ability Biologics는 시드 펀딩을 완료하고 총 1,800만 달러의 투자를 확보했습니다. 이 자금은 혁신적이고 표적화된 면역조절제 개발에 사용될 예정입니다.

세계의 면역조절제 시장 점유율, 지역별, 2023년 및 2030년
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 중국
- 일본
- 인도
- 한국
- 호주
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 사우디아라비아
- 아랍에미리트
- 남아프리카공화국
- 쿠웨이트

제7장 경쟁 상황

주요 시장 진출 기업의 최근 동향과 영향 분석
기업 분류
기업 히트맵 분석
기업 개요
- F. Hoffmann-La Roche Ltd
- Amgen Inc.
- Abbott
- Johnson & Johnson Services, Inc.
- Novartis AG
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- Merck &Co., Inc.
- Biogen
- Pfizer Inc.

ksm 24.09.24

Immunomodulators Market Growth & Trends:

The global immunomodulators market size is expected to reach USD 329.8 million by 2030, expanding at a CAGR of 6.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is anticipated to be predominantly driven by high R&D investments employed by prominent companies, resulting in the large-scale production of new and therapeutically advanced drugs. This is believed to widen the influx of drugs at an unprecedented rate into the immunomodulators market hence providing highly efficacious treatment alternatives for numerous autoimmune and inflammatory diseases.

In addition, increasing drug resistance is predicted to be responsible for boosting the clinical urgency to develop potentially new generation immunomodulators with targeted therapy mechanisms. The aforementioned factors cumulatively are expected to present significant growth opportunities over the forecast period.

Furthermore, the burgeoning presence of the key players is expected to promote the awareness levels pertaining to the benefits of immunomodulators amongst the patients as well as the physicians. This is further expected to widen the immunomodulators industry growth potential during the forecast period.

In addition, increasing adoption of monoclonal antibodies for a wide range of indications, such as, multiple sclerosis, Crohn's disease, rheumatoid arthritis, and Non-Hodgkin's Lymphoma, which is expected to boost immunomodulators industry over the forecast period. The consistent number of product approvals of highly significant monoclonal antibodies in autoimmune diseases is predicted to be responsible for widening the scope of growth.

Immunomodulators Market Report Highlights:

Immunosuppressant held the largest share of the product segment in 2023, owing to the increasing number of transplantation procedures and need to prevent organ rejection
Antibodies held the dominant share of immunosuppressant in 2023, owing to extensive utilization in kidney, liver, heart, and lung transplants resulting in greater revenue generation
Immunostimulants expected to grow lucratively as a result of the lower influx of immunostimulant generics for application in HIV, cancer and multiple sclerosis
In 2023, North America dominated the global immunomodulators market owing to the presence of a wide number of established pharmaceutical companies involved in extensive commercialization
The prominent participants are undertaking research and clinical collaborative strategies to yield new drugs and thereby to gain competitive advantage
For instance, In March 2024, Ability Biologics concluded its seed funding, securing a total of USD 18 million in investment. This capital is expected to be directed towards the development of innovative and highly targeted immunomodulators.

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Global Immunomodulators Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Global Immunomodulators Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Global Immunomodulators Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Global Immunomodulators Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Immunosuppressants
- 4.3.1. Immunosuppressants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Immunostimulants
- 4.4.1. Immunostimulants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Global Immunomodulators Market: Application Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Global Immunomodulators Market: Applicaton Movement Analysis, 2023 & 2030 (USD Million)
5.3. Oncology
- 5.3.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Respiratory
- 5.4.1. Respiratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. HIV
- 5.5.1. HIV Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Others
- 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Global Immunomodulators Market: Regional Estimates & Trend Analysis

6.1. Global Immunomodulators Market Share, By Region, 2023 & 2030 (USD Million)
6.2. North America
- 6.2.1. North America Immunomodulators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.2. U.S.
  - 6.2.2.1. U.S. Immunomodulators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.3. Canada
  - 6.2.3.1. Canada Immunomodulators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.4. Mexico
  - 6.2.4.1. Mexico Immunomodulators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Europe
- 6.3.1. Europe Immunomodulators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.2. UK
  - 6.3.2.1. UK Immunomodulators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.3. Germany
  - 6.3.3.1. Germany Immunomodulators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.4. France
  - 6.3.4.1. France Immunomodulators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.5. Italy
  - 6.3.5.1. Italy Immunomodulators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.6. Spain
  - 6.3.6.1. Spain Immunomodulators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.7. Denmark
  - 6.3.7.1. Denmark Immunomodulators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.8. Sweden
  - 6.3.8.1. Sweden Immunomodulators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.9. Norway
  - 6.3.9.1. Norway Immunomodulators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
- 6.4.1. Asia Pacific Immunomodulators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.2. China
  - 6.4.2.1. China Immunomodulators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.3. Japan
  - 6.4.3.1. Japan Immunomodulators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.4. India
  - 6.4.4.1. India Immunomodulators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.5. South Korea
  - 6.4.5.1. South Korea Immunomodulators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.6. Australia
  - 6.4.6.1. Australia Immunomodulators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.7. Thailand
  - 6.4.7.1. Thailand Immunomodulators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
- 6.5.1. Latin America Immunomodulators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.2. Brazil
  - 6.5.2.1. Brazil Immunomodulators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.3. Argentina
  - 6.5.3.1. Argentina Immunomodulators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Middle East and Africa
- 6.6.1. Middle East and Africa Immunomodulators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.2. Saudi Arabia
  - 6.6.2.1. Saudi Arabia Immunomodulators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.3. UAE
  - 6.6.3.1. UAE Immunomodulators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.4. South Africa
  - 6.6.4.1. South Africa Immunomodulators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.5. Kuwait
  - 6.6.5.1. Kuwait Immunomodulators Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
- 7.4.1. F. Hoffmann-La Roche Ltd
  - 7.4.1.1. Participant's Overview
  - 7.4.1.2. Financial Performance
  - 7.4.1.3. Product Benchmarking
  - 7.4.1.4. Recent Developments/ Strategic Initiatives
- 7.4.2. Amgen Inc.
  - 7.4.2.1. Participant's Overview
  - 7.4.2.2. Financial Performance
  - 7.4.2.3. Product Benchmarking
  - 7.4.2.4. Recent Developments/ Strategic Initiatives
- 7.4.3. Abbott
  - 7.4.3.1. Participant's Overview
  - 7.4.3.2. Financial Performance
  - 7.4.3.3. Product Benchmarking
  - 7.4.3.4. Recent Developments/ Strategic Initiatives
- 7.4.4. Johnson & Johnson Services, Inc.
  - 7.4.4.1. Participant's Overview
  - 7.4.4.2. Financial Performance
  - 7.4.4.3. Product Benchmarking
  - 7.4.4.4. Recent Developments/ Strategic Initiatives
- 7.4.5. Novartis AG
  - 7.4.5.1. Participant's Overview
  - 7.4.5.2. Financial Performance
  - 7.4.5.3. Product Benchmarking
  - 7.4.5.4. Recent Developments/ Strategic Initiatives
- 7.4.6. Eli Lilly and Company
  - 7.4.6.1. Participant's Overview
  - 7.4.6.2. Financial Performance
  - 7.4.6.3. Product Benchmarking
  - 7.4.6.4. Recent Developments/ Strategic Initiatives
- 7.4.7. Bristol-Myers Squibb Company
  - 7.4.7.1. Participant's Overview
  - 7.4.7.2. Financial Performance
  - 7.4.7.3. Product Benchmarking
  - 7.4.7.4. Recent Developments/ Strategic Initiatives
- 7.4.8. Merck & Co., Inc.
  - 7.4.8.1. Participant's Overview
  - 7.4.8.2. Financial Performance
  - 7.4.8.3. Product Benchmarking
  - 7.4.8.4. Recent Developments/ Strategic Initiatives
- 7.4.9. Biogen
  - 7.4.9.1. Participant's Overview
  - 7.4.9.2. Financial Performance
  - 7.4.9.3. Product Benchmarking
  - 7.4.9.4. Recent Developments/ Strategic Initiatives
- 7.4.10. Pfizer Inc.
  - 7.4.10.1. Participant's Overview
  - 7.4.10.2. Financial Performance
  - 7.4.10.3. Product Benchmarking
  - 7.4.10.4. Recent Developments/ Strategic Initiatives

면역조절제 시장 규모, 점유율, 동향 분석 보고서 : 솔루션별, 제품별, 용도별, 지역별, 부문별 예측(2024-2030년)

Immunomodulators Market Size, Share & Trends Analysis Report By Solution, By Product (Immunosuppressants, Immunostimulants), By Application (Oncology, Respiratory, HIV), By Region, And Segment Forecasts, 2024 - 2030

면역조절제 시장 성장 및 동향:

면역조절제 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 세계의 면역조절제 시장 변수, 동향, 범위

제4장 세계의 면역조절제 시장 : 제품별 추정·동향 분석

제5장 세계의 면역조절제 시장 : 용도별 추정·동향 분석

제6장 세계의 면역조절제 시장 : 지역별 추정·동향 분석